Trump Announces Deals to Lower Costs and Expand Coverage for Obesity Drugs
TL;DR Summary
President Trump announced a deal with Eli Lilly and Novo Nordisk to expand coverage and lower prices for obesity drugs Wegovy and Zepbound, including Medicare coverage starting next year and phased price reductions for uninsured patients, aiming to improve access and affordability of these effective treatments.
- Trump unveils deal to expand coverage and lower costs on obesity drugs Wegovy and Zepbound AP News
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
- Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost Yahoo Finance
- President Trump on Lowering Price of Weight Loss Drugs C-SPAN
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
6 min
vs 6 min read
Condensed
96%
1,186 → 46 words
Want the full story? Read the original article
Read on AP News